+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Closed System Transfer Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5303289
The global market for Closed System Transfer Devices was estimated at US$1.6 Billion in 2023 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 19.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Closed System Transfer Devices (CSTDs) Market - Key Trends & Drivers Summarized

Why Are Closed System Transfer Devices Becoming Crucial in Healthcare?

Closed System Transfer Devices (CSTDs) have become essential in healthcare environments, especially in facilities that handle hazardous drugs such as chemotherapy agents, antivirals, and other cytotoxic medications. CSTDs are engineered to prevent the escape of harmful vapors and limit exposure to healthcare professionals, protecting both patients and staff from contamination risks. They achieve this by creating an airtight seal between syringes, vials, and IV systems, ensuring that drugs are transferred in a completely closed system. This technology is particularly vital in oncology settings, where frequent handling of hazardous drugs increases the risk of exposure. CSTDs have gained prominence due to the increasing awareness of occupational hazards associated with drug handling, prompting regulatory bodies such as the Occupational Safety and Health Administration (OSHA) and the National Institute for Occupational Safety and Health (NIOSH) to recommend or mandate their use. As hospitals and pharmacies prioritize workplace safety, CSTDs are becoming indispensable tools in minimizing drug exposure risks, maintaining air quality, and ensuring safe medication practices, ultimately contributing to a safer healthcare environment.

How Are Technological Advancements Shaping the Development of CSTDs?

Technological advancements are playing a pivotal role in the evolution of Closed System Transfer Devices, enhancing their safety, usability, and compatibility with various drug delivery systems. Modern CSTDs now incorporate multi-layer filtration systems that prevent drug vapors from escaping while allowing pressure equalization, which helps minimize drug aerosolization and reduces the risk of contamination. Advanced materials, such as elastomeric and silicone-based seals, have improved device durability and compatibility with a wide range of hazardous drugs, including biologics and targeted therapies that require unique handling conditions. Additionally, some CSTDs are now designed with automated locking mechanisms and ergonomic features that allow seamless attachment and detachment, reducing the risk of accidental spillage or exposure. Smart CSTDs that can be integrated with digital health systems are also emerging, enabling real-time monitoring and tracking of drug handling activities. These advancements not only improve the safety and efficacy of CSTDs but also enhance the ease of use and compatibility with existing workflows, supporting safe drug transfer across various healthcare settings.

Which Healthcare Settings Are Driving the Demand for CSTDs Beyond Oncology?

While CSTDs are primarily used in oncology to handle chemotherapy drugs, their applications are expanding across other healthcare settings where hazardous drug handling is routine. In addition to oncology departments, CSTDs are now widely adopted in hospital pharmacies and compounding facilities, where hazardous drugs are prepared and dispensed. CSTDs help these facilities maintain compliance with safety regulations and ensure that pharmacists and technicians are protected from exposure. Hematology departments, where cytotoxic drugs are commonly used for blood disorders, are also increasingly adopting CSTDs. Long-term care facilities and home healthcare providers, where patients may require ongoing administration of hazardous medications, are seeing a growing demand for CSTDs to protect both caregivers and patients. Furthermore, CSTDs are gaining traction in veterinary medicine, where similar hazardous drug handling risks exist when treating animals with cytotoxic medications. This expanded application of CSTDs underscores their versatility and the growing recognition of occupational safety standards across diverse healthcare environments that handle potentially dangerous medications.

What's Driving Growth in the Closed System Transfer Devices Market?

The growth in the Closed System Transfer Devices market is driven by several factors, including stringent regulatory standards, increasing awareness of occupational hazards, and advancements in drug formulations. Regulatory bodies, including OSHA and NIOSH, have emphasized the importance of protecting healthcare workers from hazardous drug exposure, leading to guidelines that promote or require the use of CSTDs in drug handling. This regulatory environment has created strong demand among healthcare facilities striving for compliance and improved safety protocols. Growing awareness of occupational health risks, particularly among healthcare professionals who routinely handle hazardous drugs, has heightened the adoption of CSTDs as a preventive measure to minimize exposure. Advancements in drug formulations, such as the rise of biologics and personalized therapies, have further driven demand for CSTDs that can safely handle complex and sensitive drugs. Additionally, the increase in cancer prevalence has led to a rise in oncology treatments and hazardous drug usage, fueling market demand. Together, these factors highlight a robust growth trajectory for the CSTDs market, as healthcare facilities increasingly adopt safer practices to protect staff, patients, and the overall work environment from hazardous exposure.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Membrane-to-Membrane Systems segment, which is expected to reach US$4.4 Billion by 2030 with a CAGR of a 20.5%. The Needleless Systems segment is also set to grow at 17.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, which was estimated at $415.4 Million in 2023, and China, forecasted to grow at an impressive 25.1% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Closed System Transfer Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Closed System Transfer Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Closed System Transfer Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Closed System Transfer Devices market such as B. Braun Melsungen, Baxter International Inc., Becton, Dickinson and Company (BD), Caragen Ltd., Cardinal Health and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Closed System Transfer Devices market report include:

  • B. Braun Melsungen
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Caragen Ltd.
  • Cardinal Health
  • Carmel Pharma, Inc
  • Codan Medizinische Geräte GmbH & Co Kg
  • Corvida Medical
  • Equashield LLC.
  • Hospira (acquired by Pfizer)
  • ICU Medical, Inc.
  • JMS Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Victus, Inc.
  • Yukon Medical

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Closed System Transfer Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Emphasis on Protecting Healthcare Workers from Hazardous Drug Exposure Drives Adoption of Closed System Transfer Devices in Hospital and Clinical Settings
  • Demand for Closed System Transfer Devices Across Oncology and Pharmacy Sectors
  • Growing Global Incidence of Cancer and Increasing Use of Cytotoxic Drugs Expands Addressable Market for CSTDs in Oncology and Chemotherapy Infusion
  • Technological Advancements in Drug Delivery and Infusion Devices Drive Innovations in Closed System Transfer Devices to Enhance Safety and Efficiency
  • Increasing Focus on Reducing Drug Waste and Improving Cost-Effectiveness Strengthens the Business Case for Closed System Transfer Devices in High-Volume Healthcare Facilities
  • Rising Demand for Biologics and Complex Pharmaceuticals Expands Market Potential for CSTDs to Ensure Safe and Effective Administration
  • Heightened Awareness of the Risks Associated with Drug Contamination and Exposure in Pharmacy Settings Spurs Adoption of Closed System Transfer Solutions
  • Expansion of Home Healthcare and Outpatient Infusion Therapy Creates New Opportunities for Portable Closed System Transfer Devices
  • Growing Emphasis on Environmental Protection and Minimizing Hazardous Waste Disposal Supports Adoption of Eco-Friendly CSTDs
  • Increasing Use of Closed System Transfer Devices in Veterinary Oncology Expands Market Opportunities in Veterinary Medicine and Animal Healthcare
  • Growing Importance of Closed Systems in Compounding Pharmacies to Ensure Safety and Compliance with Hazardous Drug Handling Standards Drives Demand for CSTDs
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Closed System Transfer Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Closed System Transfer Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Closed System Transfer Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Membrane-to-Membrane Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Membrane-to-Membrane Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Membrane-to-Membrane Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Needleless Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Needleless Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Needleless Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Diaphragm-based Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Diaphragm-based Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Diaphragm-based Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Compartmentalized Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Compartmentalized Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Compartmentalized Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Air Cleaning / Filtration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Air Cleaning / Filtration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Air Cleaning / Filtration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Oncology Centers & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Oncology Centers & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Oncology Centers & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 25: World Closed System Transfer Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Vial Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 30: World Historic Review for Vial Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 31: World 16-Year Perspective for Vial Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 32: World Recent Past, Current & Future Analysis for Syringe Safety Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 33: World Historic Review for Syringe Safety Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 34: World 16-Year Perspective for Syringe Safety Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 35: World Recent Past, Current & Future Analysis for Bag / Line Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 36: World Historic Review for Bag / Line Access Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 37: World 16-Year Perspective for Bag / Line Access Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 38: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 39: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 40: World 16-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Closed System Transfer Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • B. Braun Melsungen
  • Baxter International Inc.
  • Becton, Dickinson and Company (BD)
  • Caragen Ltd.
  • Cardinal Health
  • Carmel Pharma, Inc
  • Codan Medizinische Geräte GmbH & Co Kg
  • Corvida Medical
  • Equashield LLC.
  • Hospira (acquired by Pfizer)
  • ICU Medical, Inc.
  • JMS Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Victus, Inc.
  • Yukon Medical

Table Information